Bahado-Singh Ray O, Sutton-Riley Jaime
Department of Obstetrics & Gynecology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA.
Obstet Gynecol Clin North Am. 2004 Dec;31(4):857-72, xi. doi: 10.1016/j.ogc.2004.08.010.
This article discusses biochemical screening for congenital defects. Biochemical screening remains the standard for estimating the risk of aneuploidy in pregnancy. The combination of first and second trimester markers promises to further improve diagnostic accuracy for anomaly detection.
本文讨论先天性缺陷的生化筛查。生化筛查仍然是评估孕期非整倍体风险的标准。孕早期和孕中期标志物的联合应用有望进一步提高异常检测的诊断准确性。
